NCT06939751View on ClinicalTrials.gov

OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels (Optimal)

Not yet recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

October 16, 2025

Primary Completion Date

January 1, 2031

Study Completion Date

January 1, 2032

Conditions
Cardiac FailureGraft Rejection
Trial Locations (1)

22042

Inova Health System, Falls Church

Sponsors
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Inova Health Care Services

OTHER